Theresa Matkovits, Chief Development Officer

Professional Overview

Theresa Matkovits is an experienced pharmaceutical executive with a demonstrated track record of driving innovation and successful drug development. As the Chief Development Officer at Kaléo, she is responsible for overseeing the company's research and development activities, leading cross-functional teams to advance the pipeline of novel therapeutics.

Experience Summary

Current Role

As the Chief Development Officer at Kaléo, Theresa is responsible for directing the company's drug development strategy and pipeline. She leads a team of researchers, scientists, and clinicians to design and execute complex clinical trials, manage regulatory submissions, and support the successful launch of new products. Under her leadership, Kaléo has accelerated the development of several promising drug candidates, positioning the company for continued growth and success.

Career Progression

Theresa's career in the pharmaceutical industry spans over two decades, during which she has held various leadership positions. Prior to joining Kaléo, she served as the Chief Development Officer at Matinas BioPharma, where she was instrumental in advancing the company's pipeline and securing key regulatory approvals. She has also held executive roles at ContraVir Pharmaceuticals, Inc., where she led drug development and strategic planning efforts, and at The Medicines Company, where she drove innovation in the infectious disease portfolio.

Academic Background

Theresa holds a bachelor's degree in Biochemistry from the University of Michigan and a Ph.D. in Pharmaceutical Sciences from the University of Minnesota.

Areas of Expertise

Theresa's expertise spans various areas of pharmaceutical development, including clinical trial design, regulatory affairs, product launch strategy, and cross-functional team leadership. She has a deep understanding of the regulatory landscape and has successfully navigated complex approval processes for multiple drug candidates. Her strong technical and managerial skills, combined with her industry knowledge, make her a valuable asset to the organizations she serves.

Professional Impact

Throughout her career, Theresa has played a pivotal role in the development and commercialization of several successful pharmaceutical products. She has led the implementation of innovative clinical trial protocols, secured regulatory approvals, and overseen the successful launch of new therapies. Theresa's contributions have had a significant impact on patient outcomes and the overall progress of the pharmaceutical industry.

Conclusion

Theresa Matkovits is a highly accomplished pharmaceutical executive with a proven track record of driving innovation and leading successful drug development initiatives. Her extensive experience, technical expertise, and strategic vision make her a valuable asset to Kaléo and the broader industry. As the Chief Development Officer, Theresa continues to play a crucial role in advancing the company's pipeline and delivering innovative therapies to patients in need.